大動脈瘤ステントグラフト内挿術(EVAR)のグローバル市場(2020~2030):腹部大動脈瘤(AAA)、胸部大動脈瘤(TAA)

■ 英語タイトル:Endovascular Aneurysm Repair Market By Indication (Abdominal Aortic Aneurysm (Aaa), Thoratic Aortic Aneurysm (Taa)), By Site (Infrarenal, Pararenal), By Anatomy (Traditional, Complex), By Product (Percutaneous Evar, Fenestrated Evar, Aortic Stents & Taa Graft, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

調査会社Allied Market Research社が発行したリサーチレポート(データ管理コード:ALD22AU133)■ 発行会社/調査会社:Allied Market Research
■ 商品コード:ALD22AU133
■ 発行日:2022年3月
■ 調査対象地域:グローバル
■ 産業分野:医療
■ ページ数:170
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single UserUSD5,769 ⇒換算¥853,812見積依頼/購入/質問フォーム
5 UserUSD6,450 ⇒換算¥954,600見積依頼/購入/質問フォーム
Enterprise UserUSD10,995 ⇒換算¥1,627,260見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[大動脈瘤ステントグラフト内挿術(EVAR)のグローバル市場(2020~2030):腹部大動脈瘤(AAA)、胸部大動脈瘤(TAA)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Allied Market Research社は、2020年に2,646.6百万ドルであった世界の大動脈瘤ステントグラフト内挿術(EVAR)市場が、2020年から2030年まで年平均4.8%成長し、2030年までに4,356.2百万ドルに達すると予測しています。当書では、大動脈瘤ステントグラフト内挿術(EVAR)の世界市場を対象に総合的に調査・分析を行い、イントロダクション、エグゼクティブサマリー、市場概要、疾患別(腹部大動脈瘤(AAA)、胸部大動脈瘤(TAA))分析、部位別(腎臓下、傍腎)分析、解剖術別(従来型、複雑)分析、製品別(経皮的EVAR、開窓型EVAR、大動脈ステント&TAAグラフト、その他)分析、地域別分析、企業状況、企業情報などの項目をまとめております。なお、当書に掲載されている企業情報には、Abbott Laboratories、Becton, Dickinson and Company、Cardinal Health Inc、cook medical、Endologix Inc、Lombard Medical Inc、Medtronic Plc、Koninklijke Philips N.V.、Terumo Medical Corporation、W. L. Gore & Associates Incなどが含まれています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の大動脈瘤ステントグラフト内挿術(EVAR)市場規模:疾患別(腹部大動脈瘤(AAA)、胸部大動脈瘤(TAA))
・世界の大動脈瘤ステントグラフト内挿術(EVAR)市場規模:部位別(腎臓下、傍腎)
・世界の大動脈瘤ステントグラフト内挿術(EVAR)市場規模:解剖術別(従来型、複雑)
・世界の大動脈瘤ステントグラフト内挿術(EVAR)市場規模:製品別(経皮的EVAR、開窓型EVAR、大動脈ステント&TAAグラフト、その他)
・世界の大動脈瘤ステントグラフト内挿術(EVAR)市場規模:地域別
・企業状況
・企業情報

The global endovascular aneurysm repair market was valued at $2,646.6 million in 2020 and is projected to reach $4,356.2 million by 2030, growing at a CAGR of 4.8% from 2020 to 2030.
Endovascular aneurysm repair (EVAR) is an preferred treatment option for aortic aneurysm, owing to its advantages over open surgery. These advantages include shorter hospital stay, quick recovery time, improved patient outcomes, and no abdominal surgery. Hence, this EVAR procedure is known as standard intervention for abdominal aortic aneurysm (AAA). In this procedure, a stent is placed in aneurysmal area of the aorta to provide permanent alternative channel for blood flow within the patient’s vasculature, thereby preventing aneurysmal sac from blood flow pressure and rupturing.
Although EVAR has significantly reduced operative risks and recovery time as compared to conventional open surgery, it is still possible to make improvements to the EVAR.. This is attributed to the fact that there have been cases of endoleaks post EVAR procedure. However, to meet such challenges, market players have developed next generation advanced technologies. For instance, Endologix Inc. received FDA approval for its percutaneous endograft delivery system and has a  game-changing new generation Nellix technology, the first and only endovascular sealing product beneficial  in preventing all types of endoleaks.
 
The increase in vascular diseases among population such as pulmonary embolism, cardiac disorders, and atherosclerosis, rise the demand for grafts for treatment, which, in turn, drives the growth of the  EVAR market.  . Furthermore, government is taking initiatives to increase awareness related to availability of aneurysm treatment procedures and devices. Inflated cost associated with EVAR treatment procedures and lack of awareness among people are some of the factors expected to hamper the growth of the market
 
The major players such as Terumo Medical Corporation, Koninklijike Philips N.V., and  Medtronic PLC. are adopting the product launch strategy to improve their product portfolio to maintain competition in the market. For instance, in December 2020, Terumo launched the first commercial case of aortic balloon in the U.S. This device assists physicians in the expansion of aorta, using TREO and RELAY stent-grafts in endovascular aortic repair. Such instances are expected to provide lucrative opportunities to the major players for the growth of the market.

The COVID-19 pandemic forced many companies in the global EVAR market to halt business operations for short term to comply with new government regulations, limiting the spread of the disease. This halt in operations directly impacted revenue flow of the global EVAR market. In addition, there was a halt in manufacturing of industrial products, owing to lack of raw materials and manpower in the lockdown period. Furthermore, no new consignments were received by companies that operated in this sector. Hence, halt in industrial activities and lockdowns for several months affected the global EVAR market, experiencing a gradual recovery during the forecast period.
 
The EVAR market is segmented on the basis of indication, products, site, anatomy, and region. Depending on indication, it is divided into AAA and thoracic aortic aneurysm (TAA). According to site, it is bifurcated into infrarenal and pararenal. As per the anatomy, it is categorized into traditional and complex. By product, it is segregated into percutaneous EVAR, fenestrated EVAR, aortic stents & TAA grafts and others. . By indication, the AAA segment occupied dominant share of 77.9% in 2020, and TAA is expected maintain this trend during the forecast period, owing to high occurrences of AAA disease across the globe.
Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America is expected to hold the highest market share during the forecast period.

Key Benefits For Stakeholders
●The endovascular aneurysm repair industry report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the endovascular aneurysm repair market analysis from 2020 to 2030 to identify the prevailing endovascular aneurysm repair market opportunities.
●The endovascular aneurysm repair market size research is offered along with information related to key drivers, restraints, and opportunities.
●Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
●In-depth analysis of the endovascular aneurysm repair market segmentation assists to determine the prevailing market opportunities.
●The endovascular aneurysm repair market size from 2020 to 2030 with a market drivers, and restraints. 
●Major countries in each region are mapped according to their revenue contribution to the global endovascular aneurysm repair industry.
●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
●The report includes the analysis of the regional as well as global endovascular aneurysm repair market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Indication
● Abdominal Aortic Aneurysm (Aaa)
● Thoratic Aortic Aneurysm (Taa)

By Site
● Infrarenal
● Pararenal

By Anatomy
● Traditional
● Complex

By Product
● Percutaneous Evar
● Fenestrated Evar
● Aortic Stents Taa Graft
● Others

By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ Germany
○ Italy
○ France
○ Spain
○ Rest of Europe
● Asia-Pacific
○ China
○ Japan
○ India
○ South Korea
○ Rest Of Asia Pacific
● LAMEA
○ Latin America
○ Middle East
○ Africa

● Key Market Players
○ Abbott Laboratories
○ Becton, Dickinson and Company
○ Cardinal Health Inc
○ cook medical
○ Endologix Inc
○ Lombard Medical Inc
○ Medtronic Plc
○ Koninklijke Philips N.V.
○ Terumo Medical Corporation
○ W. L. Gore & Associates Inc

*** レポート目次(コンテンツ)***

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: ENDOVASCULAR ANEURYSM REPAIR MARKET, BY INDICATION
4.1 Overview
4.1.1 Market size and forecast
4.2 Abdominal Aortic Aneurysm (Aaa)
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Thoratic Aortic Aneurysm (Taa)
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE
5.1 Overview
5.1.1 Market size and forecast
5.2 Infrarenal
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Pararenal
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
CHAPTER 6: ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY
6.1 Overview
6.1.1 Market size and forecast
6.2 Traditional
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Complex
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
CHAPTER 7: ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT
7.1 Overview
7.1.1 Market size and forecast
7.2 Percutaneous Evar
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Fenestrated Evar
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Aortic Stents & Taa Graft
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
7.5 Others
7.5.1 Key market trends, growth factors and opportunities
7.5.2 Market size and forecast, by region
7.5.3 Market analysis by country
CHAPTER 8: ENDOVASCULAR ANEURYSM REPAIR MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Indication
8.2.3 North America Market size and forecast, by Site
8.2.4 North America Market size and forecast, by Anatomy
8.2.5 North America Market size and forecast, by Product
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Indication
8.2.6.1.2 Market size and forecast, by Site
8.2.6.1.3 Market size and forecast, by Anatomy
8.2.6.1.4 Market size and forecast, by Product
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Indication
8.2.6.2.2 Market size and forecast, by Site
8.2.6.2.3 Market size and forecast, by Anatomy
8.2.6.2.4 Market size and forecast, by Product
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Indication
8.2.6.3.2 Market size and forecast, by Site
8.2.6.3.3 Market size and forecast, by Anatomy
8.2.6.3.4 Market size and forecast, by Product
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Indication
8.3.3 Europe Market size and forecast, by Site
8.3.4 Europe Market size and forecast, by Anatomy
8.3.5 Europe Market size and forecast, by Product
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Indication
8.3.6.1.2 Market size and forecast, by Site
8.3.6.1.3 Market size and forecast, by Anatomy
8.3.6.1.4 Market size and forecast, by Product
8.3.6.2 Italy
8.3.6.2.1 Market size and forecast, by Indication
8.3.6.2.2 Market size and forecast, by Site
8.3.6.2.3 Market size and forecast, by Anatomy
8.3.6.2.4 Market size and forecast, by Product
8.3.6.3 France
8.3.6.3.1 Market size and forecast, by Indication
8.3.6.3.2 Market size and forecast, by Site
8.3.6.3.3 Market size and forecast, by Anatomy
8.3.6.3.4 Market size and forecast, by Product
8.3.6.4 Spain
8.3.6.4.1 Market size and forecast, by Indication
8.3.6.4.2 Market size and forecast, by Site
8.3.6.4.3 Market size and forecast, by Anatomy
8.3.6.4.4 Market size and forecast, by Product
8.3.6.5 Rest of Europe
8.3.6.5.1 Market size and forecast, by Indication
8.3.6.5.2 Market size and forecast, by Site
8.3.6.5.3 Market size and forecast, by Anatomy
8.3.6.5.4 Market size and forecast, by Product
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Indication
8.4.3 Asia-Pacific Market size and forecast, by Site
8.4.4 Asia-Pacific Market size and forecast, by Anatomy
8.4.5 Asia-Pacific Market size and forecast, by Product
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 China
8.4.6.1.1 Market size and forecast, by Indication
8.4.6.1.2 Market size and forecast, by Site
8.4.6.1.3 Market size and forecast, by Anatomy
8.4.6.1.4 Market size and forecast, by Product
8.4.6.2 Japan
8.4.6.2.1 Market size and forecast, by Indication
8.4.6.2.2 Market size and forecast, by Site
8.4.6.2.3 Market size and forecast, by Anatomy
8.4.6.2.4 Market size and forecast, by Product
8.4.6.3 India
8.4.6.3.1 Market size and forecast, by Indication
8.4.6.3.2 Market size and forecast, by Site
8.4.6.3.3 Market size and forecast, by Anatomy
8.4.6.3.4 Market size and forecast, by Product
8.4.6.4 South Korea
8.4.6.4.1 Market size and forecast, by Indication
8.4.6.4.2 Market size and forecast, by Site
8.4.6.4.3 Market size and forecast, by Anatomy
8.4.6.4.4 Market size and forecast, by Product
8.4.6.5 Rest Of Asia Pacific
8.4.6.5.1 Market size and forecast, by Indication
8.4.6.5.2 Market size and forecast, by Site
8.4.6.5.3 Market size and forecast, by Anatomy
8.4.6.5.4 Market size and forecast, by Product
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Indication
8.5.3 LAMEA Market size and forecast, by Site
8.5.4 LAMEA Market size and forecast, by Anatomy
8.5.5 LAMEA Market size and forecast, by Product
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Latin America
8.5.6.1.1 Market size and forecast, by Indication
8.5.6.1.2 Market size and forecast, by Site
8.5.6.1.3 Market size and forecast, by Anatomy
8.5.6.1.4 Market size and forecast, by Product
8.5.6.2 Middle East
8.5.6.2.1 Market size and forecast, by Indication
8.5.6.2.2 Market size and forecast, by Site
8.5.6.2.3 Market size and forecast, by Anatomy
8.5.6.2.4 Market size and forecast, by Product
8.5.6.3 Africa
8.5.6.3.1 Market size and forecast, by Indication
8.5.6.3.2 Market size and forecast, by Site
8.5.6.3.3 Market size and forecast, by Anatomy
8.5.6.3.4 Market size and forecast, by Product
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 Abbott Laboratories
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 Becton, Dickinson and Company
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Cardinal Health Inc
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 cook medical
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Endologix Inc
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Lombard Medical Inc
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 Medtronic Plc
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 Koninklijke Philips N.V.
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 Terumo Medical Corporation
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 W. L. Gore & Associates Inc
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL ENDOVASCULAR ANEURYSM REPAIR MARKET, BY INDICATION, 2020-2030,($MILLION)
TABLE 2. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR ABDOMINAL AORTIC ANEURYSM (AAA), BY REGION , 2020-2030,($MILLION)
TABLE 3. ENDOVASCULAR ANEURYSM REPAIR MARKET ABDOMINAL AORTIC ANEURYSM (AAA) BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR THORATIC AORTIC ANEURYSM (TAA), BY REGION , 2020-2030,($MILLION)
TABLE 5. ENDOVASCULAR ANEURYSM REPAIR MARKET THORATIC AORTIC ANEURYSM (TAA) BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. GLOBAL ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE, 2020-2030,($MILLION)
TABLE 7. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR INFRARENAL, BY REGION , 2020-2030,($MILLION)
TABLE 8. ENDOVASCULAR ANEURYSM REPAIR MARKET INFRARENAL BY COUNTRY, 2020-2030,($MILLION)
TABLE 9. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR PARARENAL, BY REGION , 2020-2030,($MILLION)
TABLE 10. ENDOVASCULAR ANEURYSM REPAIR MARKET PARARENAL BY COUNTRY, 2020-2030,($MILLION)
TABLE 11. GLOBAL ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY, 2020-2030,($MILLION)
TABLE 12. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR TRADITIONAL, BY REGION , 2020-2030,($MILLION)
TABLE 13. ENDOVASCULAR ANEURYSM REPAIR MARKET TRADITIONAL BY COUNTRY, 2020-2030,($MILLION)
TABLE 14. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR COMPLEX, BY REGION , 2020-2030,($MILLION)
TABLE 15. ENDOVASCULAR ANEURYSM REPAIR MARKET COMPLEX BY COUNTRY, 2020-2030,($MILLION)
TABLE 16. GLOBAL ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 17. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR PERCUTANEOUS EVAR, BY REGION , 2020-2030,($MILLION)
TABLE 18. ENDOVASCULAR ANEURYSM REPAIR MARKET PERCUTANEOUS EVAR BY COUNTRY, 2020-2030,($MILLION)
TABLE 19. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR FENESTRATED EVAR, BY REGION , 2020-2030,($MILLION)
TABLE 20. ENDOVASCULAR ANEURYSM REPAIR MARKET FENESTRATED EVAR BY COUNTRY, 2020-2030,($MILLION)
TABLE 21. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR AORTIC STENTS & TAA GRAFT, BY REGION , 2020-2030,($MILLION)
TABLE 22. ENDOVASCULAR ANEURYSM REPAIR MARKET AORTIC STENTS & TAA GRAFT BY COUNTRY, 2020-2030,($MILLION)
TABLE 23. ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)
TABLE 24. ENDOVASCULAR ANEURYSM REPAIR MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 25. ENDOVASCULAR ANEURYSM REPAIR MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 26. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY INDICATION, 2020-2030,($MILLION)
TABLE 27. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE, 2020-2030,($MILLION)
TABLE 28. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY, 2020-2030,($MILLION)
TABLE 29. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 30. NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 31. U.S. ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 32. U.S. ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 33. U.S. ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 34. U.S. ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 35. CANADA ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 36. CANADA ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 37. CANADA ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 38. CANADA ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 39. MEXICO ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 40. MEXICO ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 41. MEXICO ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 42. MEXICO ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 43. EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET, BY INDICATION, 2020-2030,($MILLION)
TABLE 44. EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE, 2020-2030,($MILLION)
TABLE 45. EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY, 2020-2030,($MILLION)
TABLE 46. EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 47. EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 48. GERMANY ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 49. GERMANY ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 50. GERMANY ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 51. GERMANY ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 52. ITALY ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 53. ITALY ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 54. ITALY ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 55. ITALY ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 56. FRANCE ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 57. FRANCE ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 58. FRANCE ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 59. FRANCE ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 60. SPAIN ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 61. SPAIN ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 62. SPAIN ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 63. SPAIN ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 64. REST OF EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 65. REST OF EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 66. REST OF EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 67. REST OF EUROPE ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 68. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET, BY INDICATION, 2020-2030,($MILLION)
TABLE 69. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE, 2020-2030,($MILLION)
TABLE 70. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY, 2020-2030,($MILLION)
TABLE 71. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 72. ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 73. CHINA ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 74. CHINA ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 75. CHINA ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 76. CHINA ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 77. JAPAN ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 78. JAPAN ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 79. JAPAN ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 80. JAPAN ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 81. INDIA ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 82. INDIA ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 83. INDIA ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 84. INDIA ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 85. SOUTH KOREA ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 86. SOUTH KOREA ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 87. SOUTH KOREA ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 88. SOUTH KOREA ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 89. REST OF ASIA PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 90. REST OF ASIA PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 91. REST OF ASIA PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 92. REST OF ASIA PACIFIC ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 93. LAMEA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY INDICATION, 2020-2030,($MILLION)
TABLE 94. LAMEA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY SITE, 2020-2030,($MILLION)
TABLE 95. LAMEA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY ANATOMY, 2020-2030,($MILLION)
TABLE 96. LAMEA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 97. LAMEA ENDOVASCULAR ANEURYSM REPAIR MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 98. LATIN AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 99. LATIN AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 100. LATIN AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 101. LATIN AMERICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 102. MIDDLE EAST ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 103. MIDDLE EAST ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 104. MIDDLE EAST ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 105. MIDDLE EAST ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 106. AFRICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 107. AFRICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY SITE 2020-2030,($MILLION)
TABLE 108. AFRICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY ANATOMY 2020-2030,($MILLION)
TABLE 109. AFRICA ENDOVASCULAR ANEURYSM REPAIR MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 110.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 111.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 112.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 113.ABBOTT LABORATORIES: NET SALES,
TABLE 114.ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 115.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 116.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 117.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 118.BECTON, DICKINSON AND COMPANY: NET SALES,
TABLE 119.BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
TABLE 120.CARDINAL HEALTH INC: COMPANY SNAPSHOT
TABLE 121.CARDINAL HEALTH INC: OPERATING SEGMENTS
TABLE 122.CARDINAL HEALTH INC: PRODUCT PORTFOLIO
TABLE 123.CARDINAL HEALTH INC: NET SALES,
TABLE 124.CARDINAL HEALTH INC: KEY STRATERGIES
TABLE 125.COOK MEDICAL: COMPANY SNAPSHOT
TABLE 126.COOK MEDICAL: OPERATING SEGMENTS
TABLE 127.COOK MEDICAL: PRODUCT PORTFOLIO
TABLE 128.COOK MEDICAL: NET SALES,
TABLE 129.COOK MEDICAL: KEY STRATERGIES
TABLE 130.ENDOLOGIX INC: COMPANY SNAPSHOT
TABLE 131.ENDOLOGIX INC: OPERATING SEGMENTS
TABLE 132.ENDOLOGIX INC: PRODUCT PORTFOLIO
TABLE 133.ENDOLOGIX INC: NET SALES,
TABLE 134.ENDOLOGIX INC: KEY STRATERGIES
TABLE 135.LOMBARD MEDICAL INC: COMPANY SNAPSHOT
TABLE 136.LOMBARD MEDICAL INC: OPERATING SEGMENTS
TABLE 137.LOMBARD MEDICAL INC: PRODUCT PORTFOLIO
TABLE 138.LOMBARD MEDICAL INC: NET SALES,
TABLE 139.LOMBARD MEDICAL INC: KEY STRATERGIES
TABLE 140.MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 141.MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 142.MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 143.MEDTRONIC PLC: NET SALES,
TABLE 144.MEDTRONIC PLC: KEY STRATERGIES
TABLE 145.KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 146.KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
TABLE 147.KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 148.KONINKLIJKE PHILIPS N.V.: NET SALES,
TABLE 149.KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES
TABLE 150.TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT
TABLE 151.TERUMO MEDICAL CORPORATION: OPERATING SEGMENTS
TABLE 152.TERUMO MEDICAL CORPORATION: PRODUCT PORTFOLIO
TABLE 153.TERUMO MEDICAL CORPORATION: NET SALES,
TABLE 154.TERUMO MEDICAL CORPORATION: KEY STRATERGIES
TABLE 155.W. L. GORE & ASSOCIATES INC: COMPANY SNAPSHOT
TABLE 156.W. L. GORE & ASSOCIATES INC: OPERATING SEGMENTS
TABLE 157.W. L. GORE & ASSOCIATES INC: PRODUCT PORTFOLIO
TABLE 158.W. L. GORE & ASSOCIATES INC: NET SALES,
TABLE 159.W. L. GORE & ASSOCIATES INC: KEY STRATERGIES

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(ALD22AU133 )"大動脈瘤ステントグラフト内挿術(EVAR)のグローバル市場(2020~2030):腹部大動脈瘤(AAA)、胸部大動脈瘤(TAA)" (英文:Endovascular Aneurysm Repair Market By Indication (Abdominal Aortic Aneurysm (Aaa), Thoratic Aortic Aneurysm (Taa)), By Site (Infrarenal, Pararenal), By Anatomy (Traditional, Complex), By Product (Percutaneous Evar, Fenestrated Evar, Aortic Stents & Taa Graft, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。